Back to Search
Start Over
EE656 A Cost-Utility Analysis of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, a Rare Disease, in Spain.
- Source :
-
Value in Health . 2022 Suppl, Vol. 25 Issue 12, pS185-S185. 1p. - Publication Year :
- 2022
- Subjects :
- *COST effectiveness
*RARE diseases
*VASCULITIS
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 25
- Issue :
- 12
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 160759010
- Full Text :
- https://doi.org/10.1016/j.jval.2022.09.895